DNAJB1-PRKACA peptide vaccine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Hiltonol® (Poly-ICLC)

Filter by location:

Baltimore, Maryland1 trial

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Sidney Kimmel Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.